Detalhe da pesquisa
1.
Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome.
Brain
; 145(10): 3383-3390, 2022 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737950
2.
Decellularized organ biomatrices facilitate quantifiable in vitro 3D cancer metastasis models.
Soft Matter
; 18(31): 5791-5806, 2022 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35894795
3.
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization.
Cancer Cell Int
; 21(1): 266, 2021 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001143
4.
TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth.
Proc Natl Acad Sci U S A
; 112(25): E3216-25, 2015 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26063617
5.
Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
Breast Cancer Res Treat
; 146(1): 211-20, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24839032
6.
Ku must load directly onto the chromosome end in order to mediate its telomeric functions.
PLoS Genet
; 7(8): e1002233, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21852961
7.
Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation.
Proc Natl Acad Sci U S A
; 107(8): 3728-33, 2010 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20133707
8.
Research Silos in Cancer Disparities: Obstacles to Improving Clinical Outcomes for Underserved Patient Populations.
Clin Cancer Res
; 29(7): 1194-1199, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638200
9.
Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer.
Int J Environ Res Public Health
; 20(4)2023 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36833598
10.
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness.
Sci Adv
; 9(26): eadf2860, 2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390209
11.
Segregating YKU80 and TLC1 alleles underlying natural variation in telomere properties in wild yeast.
PLoS Genet
; 5(9): e1000659, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19763176
12.
The DNA damage repair landscape in Black women with breast cancer.
Ther Adv Med Oncol
; 14: 17588359221075458, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35154416
13.
HER2 Activation and Endocrine Treatment Resistance in HER2-negative Breast Cancer.
Endocrinology
; 162(10)2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320193
14.
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer.
Nat Commun
; 12(1): 2940, 2021 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011995
15.
CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree?
Clin Cancer Res
; 26(1): 3-5, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31690650
16.
Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.
Nat Neurosci
; 23(7): 842-853, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32424282
17.
Endocrine therapy resistance: new insights.
Breast
; 48 Suppl 1: S26-S30, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31839155
18.
Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers.
Clin Cancer Res
; 24(19): 4887-4899, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29793947
19.
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.
Cell Rep
; 24(6): 1434-1444.e7, 2018 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30089255
20.
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.
Cancer Discov
; 7(10): 1168-1183, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801307